Market Overview:
Bioactive peptides are short chains of amino acids that have physiological functions beyond their roles as building blocks of proteins. They influence biological processes and induce impacts on metabolism, vascular and inflammatory responses, and gene expression. Bioactive peptides are important ingredients in functional foods and nutraceuticals due to their various health-promoting properties.
Market key trends:
One of the key trends in the bioactive peptide market is the growing demand for peptides in animal feed. Many research studies have shown that adding specific bioactive peptides to cattle feed can improve growth performance, protein synthesis, gut health, and resistance to diseases. For example, lactotripeptides derived from milk proteins have shown positive effects on animal growth and immunity. They stimulate the proliferation of beneficial bacteria in the gut while inhibiting pathogens. This helps promote overall digestive health of cattle. The recognition of such benefits is fueling the use of customized peptide formulations in cattle and poultry feed.
Segment Analysis
The bioactive peptide market is dominated by collagen peptides, accounting for over 30% of the market share. Collagen peptides are widely used in nutritional supplements, functional foods and beverages due to its benefits in improving skin health, joint health and digestive health. The anti-aging effects of collagen peptides have increased its demand substantially in the cosmetic industry.
The global Bioactive Peptide Market Growth is estimated to be valued at US$ 9.8 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Key Takeaways
The global bioactive peptide market is expected to witness high growth, exhibiting CAGR of 9.4% over the forecast period, due to increasing demand for functional foods and dietary supplements containing bioactive peptides.
Regional analysis
North America dominates the global bioactive peptide market currently and is expected to continue its dominance during the forecast period. This is attributed to increasing health consciousness and growing dietary supplement industry in the US and Canada. Asia Pacific is expected to be the fastest growing market for bioactive peptides due to rising incomes, growing middle class population and their willingness to spend on health and wellness products in countries like China and India.
Key players
Key players operating in the bioactive peptide market are Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy, GenScript, HELIX BIOMEDIX, Oryn Therapeutics, Selecta Biosciences, NIBEC, vivitide, PEPTIDE INSTITUTE, INC, BCN Peptides, Setlance srl., APEPTICO Forschung und Entwicklung GmbH, and BIONANOPLUS.
